Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: MAT

Rugiet Men Makes Obtaining ED Medication Easy with Telehealth Consultations and Home Delivery


MIAMI, April 7, 2020 /PRNewswire/ -- As greater numbers of Americans are forced to stay home during the COVID-19 crisis, Rugiet Men?providing men access to the fast- acting, sublingual, ED medication Rugiet Ready--is providing a lifeline for men suffering from erectile dysfunction by delivering ED medication directly to their home. 

Rugiet Men was already leading the way in the sexual wellness telehealth revolution, providing men with access to tailored medications delivered right to their doorstep after only a short online consultation with a doctor. Their online portal allows for a quick online consultation, a customized prescription chosen specifically for each customer, and delivery to their doorstep after only a few short days. 

For men unable to leave their home due to the COVID-19 outbreak, Rugiet Men's easy telehealth prescription and home delivery option is a welcome alternative to a trip to the pharmacy or doctor's office.

Via their telehealth system, Rugiet Men customers consult with affiliated doctors and decide on what combination and dosage of reliable sildenafil and tadalafil medications will best work for them. The result is a prescription tailored specifically to their medical history and requests; a truly one-of-a-kind product.

A sublingual product that easily dissolves under the tongue, Rugiet Ready is fast acting, easy to use, requires a lower dosage, and has been proven to be very effective. Rugiet Ready is made in a licensed U.S. pharmacy, using only FDA approved active ingredients?a combination of sildenafil (the active ingredient in Viagra) and tadalafil (the active ingredient in Cialis)?optimized for each customer based on their online consultation with a prescribing doctor.

"We're dedicated to helping men take charge of their sexual health, and if we can make that easier during a crisis, we're proud to do so," said Dr. Khanpara, MD, Chief Medical Officer.

Chief Executive Officer, Vikas Patel added, "Driving awareness and providing access to sublingual dosage forms for ED and other underserved disease states has been our mission from day one, and to that end, we are closely monitoring the pilot study exploring sildenafil as a treatment for COVID-19 (https://www.latimes.com/science/story/2020-04-05/viagra-discovery-could-treat-coronavirus-patients).  If the study shows benefit, we believe that our sublingual route of delivery will prove advantageous in a clinical setting given its fast onset time."

Rugiet Ready is currently available in New York, Florida and Colorado with additional states soon to follow. To learn more about Rugiet Men and Rugiet Ready, visit www.rugietmen.com

About Rugiet Men: Rugiet Men began with the idea that everyone should make their sexual health a priority, and in a time where the majority of the population leads fast-paced and busy lives, prioritizing your sexual health has never been so important. Through our carefully crafted online platform, it has never been easier for you to discreetly and easily take control. Learn more about Rugiet Men at www.rugietmen.com

SOURCE Rugiet Men


These press releases may also interest you

at 10:02
Boston Institute of Biotechnology, LLC (BIB) in collaboration with BIBo-Biopharma, proudly announces the successful completion of a groundbreaking 30,000L fermentation run, marking a significant milestone in biotechnology history....

at 10:00
Minister Responsible for Relations with the First Nations and the Inuit Ian Lafrenière today submitted in the National Assembly the third annual report on the administration of the Act to authorize the communication of personal information to the...

at 10:00
Cobb Outpatient Detox has opened a new facility in Marietta, GA, providing outpatient drug and alcohol detox services. The center aims to assist individuals in overcoming addiction while balancing their work and family commitments. Located near major...

at 10:00
A new report from the Health Care Cost Institute (HCCI) shows that, even with fluctuations in 2020 and 2021, per person health care spending grew from 2018 to 2022. Over the five years, average prices increased by 14% and utilization went up by about...

at 10:00
BioInnovation Institute (BII), an international non-profit foundation, incubating and accelerating world-class life science research, today announces the launch of the BII & Science Translational Medicine Prize for Innovations in Women´s Health and...

at 10:00
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain, announced that the Phase I/II clinical study results of the novel Nectin-4-targeting ADC 9MW2821 for multiple advanced solid tumors will be presented...



News published on and distributed by: